GoLoCypro: Titrating the lowest effective dose of cyproterone acetate for treatment of trans and gender diverse people who request feminizing hormones (2019–2021)

Grant type:
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Researchers:
  • Senior Research Fellow
    School of Public Health
    Faculty of Medicine
Funded by:
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine